v3.26.1
Revenues and Trade Receivables, Net (Tables)
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue
The Company's revenues were comprised of the following:
 Three Months Ended
March 31,
 20262025
Manufacture and supply revenue$8,793 $7,193 
License and royalty revenue a
5,395 790 
Co-development and research fees258 418 
Proprietary product revenue, net— 319 
Total revenues$14,446 $8,720 
a.Zevra-related royalty revenue of $4,500 recognized during the three months ended March 31, 2026. For additional information, see Note 6, Material Agreements.
Schedule of Disaggregation of Revenue
The following table provides disaggregated net revenue by geographic area:
 Three Months Ended
March 31,
 20262025
United States$13,245 $5,201 
Ex-United States1,201 3,519 
Total revenues$14,446 $8,720 
Schedule of Trade and Other Receivables, Net
Trade and other receivables, net consist of the following:
 March 31,
2026
December 31,
2025
Trade receivables$5,262 $8,013 
Contract and other receivables1,605 9,750 
Less: sales-related allowances— (582)
Reclassification into Accrued distribution expenses and sales-related allowances
— 582 
Trade and other receivables, net$6,867 $17,763 
Schedule of Sales-related Allowances
The following tables provides a summary of activity with respect to sales-related allowances:
 March 31,
2026
December 31,
2025
Balance at beginning of period
$— $48 
Provision— 568 
Payments / credits— (34)
Reclassification into Accrued distribution expenses and sales-related allowances
— (582)
Balance at end of period
$— $—